Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation

Detalles Bibliográficos
Autores principales: Zhao, Hua‑fu, Wu, Chang‑peng, Zhou, Xiu‑ming, Diao, Peng‑yu, Xu, Yan‑wen, Liu, Jing, Wang, Jing, Huang, Xian‑jian, Liu, Wen‑lan, Chen, Zhong‑ping, Huang, Guo‑dong, Li, Wei‑ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320197/
https://www.ncbi.nlm.nih.gov/pubmed/34321007
http://dx.doi.org/10.1186/s12935-021-02028-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320197/
https://www.ncbi.nlm.nih.gov/pubmed/34321007
http://dx.doi.org/10.1186/s12935-021-02028-1

Ejemplares similares